CAJ | 학술논문

目的：探讨厄贝沙坦联合低分子肝素治疗肺心病心力衰竭临床疗效。方法收集我院收治的100例肺心病心力衰竭患者，将所有患者分为观察组和对照组，每组50例。对照组使用常规方法实施治疗，观察组使用厄贝沙坦联合低分子肝素实施治疗。结果观察组在治疗完成后的临床治疗效果高于对照组，P＜0.05，差异具有统计学意义。结论在对于肺心病心力衰竭患者实施治疗的过程中，厄贝沙坦联合低分子肝素效果更佳。
목적：탐토액패사탄연합저분자간소치료폐심병심력쇠갈림상료효。방법수집아원수치적100례폐심병심력쇠갈환자，장소유환자분위관찰조화대조조，매조50례。대조조사용상규방법실시치료，관찰조사용액패사탄연합저분자간소실시치료。결과관찰조재치료완성후적림상치료효과고우대조조，P＜0.05，차이구유통계학의의。결론재대우폐심병심력쇠갈환자실시치료적과정중，액패사탄연합저분자간소효과경가。
Objective To evaluate evaluate the clinical efifcacy of irbesartan combine with low molecular heparin in treatment of pulmonary heart disease heart failure. Methods Selected 100 cases with pulmonary heart disease heart failure in our hospital, were divided into the observation group and the control group, each group had 50 cases. The control group patients used conventional methods to implement treatment, and the observation group used he sand with low molecular heparin therapy. Results The observation group in treatment of the clinical treatment effect was higher than the control group after ifnishing, P<0.05, had difference statistically signiifcance. Conclusion Carried out in treatment for heart failure patients with pulmonary heart disease heart failure in irbesartan combine with low molecular heparin effect is better.